Wegovy is a self-administered injection pen containing semaglutide
If you want individualized guidance or want to learn how Mochi supports patients through plateaus, you can check your eligibility here
Unresolved safety questions The staff review identified uncertainty about immunogenicity, aggregation, peptide-related impurities, hypersensitivity, route-specific risk, repeated exposure, and long-term use
If prolonged poor intake, vomiting, or highly restrictive diets occur, micronutrient deficiencies may develop and should be assessed
Pediatric Administration: Safety and Dosage While less commonly used in children, dosing for pediatric patients is carefully calculated based on body weight and the specific medical condition being treated, with vigilant monitoring for growth and development impacts